Location History:
- Frederick, MD (US) (2008)
- Monrovia, MD (US) (2012 - 2013)
Company Filing History:
4 out of 4 
4 out of 38 
Years Active: 2008-2013
Title: Barbara T. Solow: Innovator in Protective Antigen Research
Introduction
Barbara T. Solow is a distinguished inventor based in Monrovia, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of protective antigens. With a total of 4 patents to her name, her work has had a profound impact on vaccine development and public health.
Latest Patents
Among her latest patents is the "Preparation of Protective Antigen," which involves a polynucleotide sequence encoding recombinant Protective Antigen (rPA). This patent provides expression vectors and host cells that incorporate the polynucleotide sequence, along with methods for producing rPA. This innovative approach is crucial for advancing vaccine technologies.
Career Highlights
Barbara has worked with notable organizations such as Dynport Vaccine Company LLC and the Health Protection Agency. Her expertise in the field has allowed her to contribute to important research and development projects aimed at enhancing vaccine efficacy and safety.
Collaborations
Throughout her career, Barbara has collaborated with esteemed colleagues, including Ian McEntee and Philip Vincent. These partnerships have fostered a collaborative environment that promotes innovation and scientific advancement.
Conclusion
Barbara T. Solow's contributions to the field of protective antigens exemplify her dedication to improving public health through innovative research. Her patents and collaborations highlight her role as a leading inventor in biotechnology.